Introduction
============

MicroRNAs (miRNAs) are short noncoding RNA molecules, usually between 22 and 23 nucleotides in length, which regulate the expression of protein-coding genes at the post-transcriptional level by interfering with the translation of mRNAs or by inducing their degradation ([@b1-mmr-16-05-6608]). In humans, miRNAs have been proposed to regulate \~60% of all protein-coding genes and fulfill regulatory functions, as established by their involvement in numerous processes and diseases ([@b2-mmr-16-05-6608],[@b3-mmr-16-05-6608]). In addition, previous studies have reported that miRNAs are involved in the self-renewal and cell-fate decisions of stem cells, control of the cell cycle, and maintenance of the balance of keratinocyte proliferation, differentiation and apoptosis, whereas their aberrant expression can lead to disease development ([@b4-mmr-16-05-6608],[@b5-mmr-16-05-6608]). For example, our previous study ([@b6-mmr-16-05-6608]) observed them iRNA expression profiles of epidermal cells at various stages of differentiation; concluding that the expression of 191 miRNAs was significantly altered, the target genes of which are closely correlated with cell proliferation, differentiation, apoptosis and migration. Furthermore, Liu *et al* ([@b7-mmr-16-05-6608]) detected a significant differential miRNA expression profile in cutaneous wounds between diabetic rats and normal rats, which may be closely associated with the mechanisms underlying diabetic wound healing. Sonkoly *et al* ([@b8-mmr-16-05-6608]) reported that upregulation of miR-203 in human keratinocytes may be required for their differentiation, which is dependent on activation of the protein kinase C (PKC)/activator protein-1 (AP-1) pathway. Conversely, pretreatment with the specific PKC inhibitor, GF109203X, not only suppressed 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced miR-203 expression, but also suppressed it to below the basal level. A downstream target for PKC action in keratinocytes is AP-1, which is a transcription factor that consists of homodimers or heterodimers of the Jun and Fos families of nuclear proteins, and serves essential roles in the regulation of keratinocyte growth and differentiation ([@b8-mmr-16-05-6608]). miRNAs regulate keratinocyte differentiation by activating the PKC signaling pathway; however, to the best of our knowledge, there are currently no reports on the differential miRNA expression profiles of keratinocytes following treatment with the specific PKC inhibitor, GF109203X.

PKC was initially discovered in 1977 as a proteolytically activated protein kinase. Later, it was verified as a Ca^2+^-activated, phospholipid-dependent Ser/Thr kinase, firmly associated with signal transduction ([@b9-mmr-16-05-6608]). PKC family isoforms are divided into three subgroups: The calcium- and phorbol ester-dependent 'classical/conventional' subgroup (PKCα, βI, βII, γ), the calcium-independent 'novel' subgroup (PKC σ, δ, ε, η, θ) and the calcium- and phorbol ester-independent 'atypical' subgroup (PKC ζ, ι, λ) ([@b9-mmr-16-05-6608]). The rapid activation of PKC enzymes forms part of the signal transduction pathways elicited by numerous hormones, and their phosphorylation of target proteins leads to various cellular responses, including cell proliferation, differentiation and apoptosis ([@b10-mmr-16-05-6608]). In keratinocytes, several cellular functions are also mediated by signaling via PKC, including translocation of the desmoyokin/AHNAK protein, inhibition of proliferation, and differentiation ([@b11-mmr-16-05-6608]). GF109203X is a specific inhibitor of PKC, which competes at the ATP-binding site and regulates the development of keratinocytes. Le Panse *et al* ([@b12-mmr-16-05-6608]) indicated that GF109203X inhibited c-Fos and c-Jun mRNA expression; in keratinocytes these proto-oncogenes are involved in the cellular differentiation process rather than in cellular proliferation. In addition, it has been verified that GF109203X effectively inhibits granular cell differentiation marker expression when used at 1 and 5 µM concentrations; however, it does not alter keratin (K)1 or K14expression ([@b13-mmr-16-05-6608]). GF109203X has also been reported to block TPA-induced tumor susceptibility gene 101 protein and K10 upregulation during early keratinocyte differentiation ([@b14-mmr-16-05-6608]). Furthermore, keratinocyte differentiation is preceded by a commitment to irreversible cell cycle withdrawal, and GF109203X may induce marked protection from loss of growth potential in human keratinocytes ([@b15-mmr-16-05-6608]). GF109203X may also suppress the ultraviolet B-induced reduction of cell survival, caspase-9 activation, downregulation of human inhibitor of apoptosis protein-1, X-linked inhibitor of apoptosis proteinand PKB (but not myeloid cell leukemia-1), and upregulation of glucose-regulated protein 78 in HaCaT cells ([@b16-mmr-16-05-6608]). Overall, these data indicated that GF109203X may have influence on keratinocyte differentiation. However, the miRNA profiles and biological characteristics of keratinocytes induced by specific PKC inhibitors have yet to be elucidated.

The present study aimed to explore the differential miRNA expression profile and biological characteristics of keratinocytes treated with the specific PKC inhibitor, GF109203X. The findings of the present study may provide a novel approach for wound healing and regeneration of skin tissues.

Materials and methods
=====================

### Sample collection

Prepuce samples were obtained from 5 male patients (age, 16--30 years) who were healthy patients except their prepuce was too long and underwent circumcision at the Department of Urology Surgery, The First Affiliated Hospital of Nanchang University (Nanchang, China) between March 2014 and April 2014. The present study was conducted in accordance with the Declaration of Helsinki, with approval obtained from the Nanchang University Ethics Committee. Written informed consent was obtained from all participants.

### Cell culture and identification

The epidermis was digested with trypsin (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 4°C in the dark for 8 h. Rapid adhesion to collagen IV (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was used to isolate human differentiated keratinocytes from epidermal stem cells, as previously described ([@b6-mmr-16-05-6608]). The differentiated keratinocytes were cultured in vitro in keratinocyte serum-free medium supplemented with 10 µg/l epidermal growth factor and 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) at 37°C in a humidified chamber with 5% CO2 for 2 days, and were then divided into two groups. In the experimental group (EXP), the primary keratinocytes were treated with GF109203X (Selleck Chemicals, LLC, Houston, TX, USA) for 2 days, at a final concentration of 10 µM. In the control group (CON), the primary keratinocytes were treated with dimethyl sulfoxide (DMSO; Sigma-Aldrich; Merck KGaA) for 2 days, at a final concentration of 10 µM. The cellular morphology of the two groups was observed under an inverted phase contrast microscope (CTR6000; Leica Microsystems GmbH, Wetzlar, Germany). Immunostaining of integrin β1 (catalog no. AW5254), cytokeratin (CK)19 (catalog no. AM8477b), CK1 (catalog no. AP9695c) and CK10 (catalog no. AP6704c; Abgent Inc., San Diego, CA, USA) was used for cell identification, which was performed according to the manufacturer\'s protocols.

### Extraction of total RNA

Total RNA was isolated using TRIzol (Invitrogen; Thermo Fisher Scientific. Inc.) and purified with the RNeasy mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer\'s protocol. RNA quality and quantity were measured using a NanoDrop spectrophotometer (ND-1000; NanoDrop; Thermo Fisher Scientific, Inc., Wilmington, DE, USA) and RNA integrity was determined by electrophoresis on a denaturing agarose gel, which was prepared in house. On the denaturing gel, the 28S and 18S ribosomal RNA bands were visible, which suggested that the extracted total RNA was complete, RNA degradation and contamination were low and the extracted total RNA exhibited high levels of purity.

### miRNA labeling and array hybridization

After quality control, miRNA was labeled with the miRCURY™ Power Labeling kit (Exiqon A/S, Vedbaek, Denmark) according to the manufacturer\'s protocol. Briefly, 5 µl calf intestine phosphatase (CIP) reaction solution (1 µl total RNA, 0.5 µl CIP buffer, 0.5 µl CIP and 3 µl ddH2O) was incubated at 37°C for 30 min, and then at 95°C for 5 min to terminate the reaction. Subsequently, 3.0 µl labeling buffer, 1.5 µl fluorescent label (Hy3™), 2.0 µl DMSO and 2.0 µl labeling enzyme were added to the mixture. The system was incubated at 16°C for 1 h, and subsequently at 65°C for 15 min to terminate the labeling reaction. The Hy3™-labeled samples were hybridized on the miRCURY™ LNA Array (v.18.0) (Exiqon A/S) according to the manufacturer\'s protocol. Briefly, 25 µl Hy3™-labeled samples were mixed with 25 µl hybridization buffer and were denatured for 2 min at 95°C, after which the samples were incubated on ice for 2 min and hybridized to the microarray for 16--20 h at 56°C in a 12-Bay Hybridization system (Roche Nimblegen, Inc., Madison, WI, USA). Following hybridization, the slides were obtained and washed several times using a wash buffer kit (Exiqon A/S). Finally, the slides were scanned using the Axon GenePix 4000B Microarray Scanner (Axon Instruments; Molecular Devices, LLC, Sunnyvale, CA, USA).

### Data processing and analysis

Scanned images were then imported into GenePix Pro 6.0 software (Axon Instruments; Molecular Devices, LLC) for grid alignment and data extraction. Replicated miRNAs were averaged and miRNAs withintensities ≥30 in all samples were chosen for calculating the normalization factor. Expressed data were normalized using the median normalization. Following normalization, significant differentially expressed miRNAs between the two groups were identified through fold change and P-value (fold change \>2 and P\<0.05). Differential miRNA expression between the two cell groups was analyzed using a Student\'s t-test. Finally, hierarchical clustering was performed to detect distinguishable miRNA expression profiling among samples.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and miRNA target prediction

According to the microarray results, the expression levels of hsa-miR-1-3p were upregulated and the expression levels of hsa-miR-31-5p were downregulated in the experimental group compared with the control group, exhibiting strong original signals and clear differences. Therefore, both of these miRNAs were selected for RT-qPCR verification. In RT-qPCR, small nuclear (sn)RNA U6 was used as an endogenous control. Firstly, cDNA was synthesized using a Gene Amp PCR system 9700 (Applied Biosystems, Thermo Fisher Scientific, Inc.). RT was performed in a 20 µl reaction containing 200 ng total RNA, 0.3 µl 1 µM RT primer, 2 µl 2.5 mM dNTP (HyTest Ltd, Turku, Finland), 2 µl 10× RT buffer (Epicentre; Illumina, Inc., San Diego, CA, USA), 1 µl 50 U/µl RT enzyme (Epicentre; Illumina, Inc.), 0.3 µl 40 U/µl RNase inhibitor (Epicentre; Illumina, Inc.), 20 µl nuclease free water and 0.2 µl MMLV High Performance Reverse Transcriptase (Epicentre; Illumina, Inc.). The stem-loop RT reaction was performed at 16°C for 30 min, followed by 42°C for 30 min and 85°C for 5 min. A total of 2 µl RT reaction was then used with 1 µl specific primers for each of the hsa-miR-1-3p and hsa-miR-31-5p in triplicate wells for PCR on an Applied Biosystems ViiA 7 Real-time PCR system (Applied Biosystems, Thermo Fisher Scientific, Inc.). The thermal cycling parameters were as follows: An initial predenaturation step at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 10 sec, annealing at 60°C for 60 sec, followed by 95°C for 10 sec, 60°C for 60 sec and 95°C for 15 sec. The primers, which were synthesized by Bioligo Life Technology (Shanghai, China) and the sequences are presented in [Table I](#tI-mmr-16-05-6608){ref-type="table"}. Expression levels were calculated using the comparative quantitative cycle (Cq) method ([@b17-mmr-16-05-6608]). RT-qPCR was performed in triplicate for each treatment group. To demonstrate the function of differential miRNAs, target gene prediction and functional analysis were conducted. The following websites: <http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/> and <http://www.targetscan.org/were> used to predict target genes of the differentially expressed miRNAs. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were used to identify the roles of these target genes in biological pathways or GO terms, which were accessed from the databases of <http://www.geneontology.org/> and <http://www.genome.jp/kegg/>, respectively.

Results
=======

### Biological characteristics of the cells

Non-adherent cells were irregular in shape, size and distribution after culturing for 2 days, and were loosely attached to the plate wells with no clones detected under an inverted microscope. These results suggested that the characteristics of non-adherent cells were in accordance with terminally differentiating epidermal keratinocytes. In the experimental group, parts of the keratinocytes induced by GF109203X attached to the well and formed clones, and the expression of CK19, CK14 and integrin β1 was positive, whereas CK10 expression was negative, which is in agreement with the characteristics of epidermal-like stem cells (data not shown). However, in the control group, the number of cells was significantly decreased with no clones detected, and the expression of CK10 was positive, whereas the expression of CK19, CK14 and integrin β1 was negative, which is in accordance with the characteristics of terminally differentiating epidermal keratinocytes.

### Extraction and qualification of total RNA

The A260/A280 ratio of RNA is a method used to detect RNA purity; samples \~2.0 are considered to represent pure RNA. A ratio \<1.8 indicates sample contamination. A ratio \>2.0 indicates RNA hydrolysis. Therefore, a ratio range between 1.8 and 2.1 is considered acceptable. In addition, the A260/A230 ratio should be \>1.8 for pure RNA. As demonstrated in [Table II](#tII-mmr-16-05-6608){ref-type="table"}, the extracted RNAs conformed to the quality standards and therefore qualified for the subsequent miRNA experiments. On the denaturing electrophoresis gel ([Fig. 1](#f1-mmr-16-05-6608){ref-type="fig"}), the 18S and 28S rRNA bands were clearly visible in the RNA samples, suggesting good integrity.

### Differential miRNA expression

The miRNA expression variations and patterns between the two groups are presented in [Fig. 1B and C](#f1-mmr-16-05-6608){ref-type="fig"}. According to data processing and analysis, a total of 45 miRNAs were upregulated, whereas 34 miRNAs were downregulated in the experiment group compared with expression in the control group ([Table III](#tIII-mmr-16-05-6608){ref-type="table"}). The miRNAs with the greatest upregulation and downregulation were hsa-miR-1-3p (5.0265-fold) and hsa-miR-31-5p (13.9011-fold), respectively.

### Verification of the microarray data by RT-qPCR

In order to verify the microarray results, RT-qPCR assays were performed on selected miRNAs (hsa-miR-1-3p and hsa-miR-31-5p) in the EXP and CON groups. Amplification and dissociation curve charts for hsa-miR-1-3p, hsa-miR-31-5p and snRNA U6 were generated ([Fig. 2](#f2-mmr-16-05-6608){ref-type="fig"}). The 2^−ΔΔCq^ value of the miRNAs was calculated according to the relative quantitative method. The 2^−ΔΔCq^ analysis revealed an upregulation of hsa-miR-1-3p (1.724) and downregulation of hsa-miR-31-5p (0.458), which is consistent with the microarray results, thus suggesting that the microarray data were reliable.

### Prediction of target genes

To demonstrate the function of differential miRNAs, target gene prediction and functional analysis were conducted. Databases of identified target genes can be accessed to compile potential targets for differential miRNAs, due to the development of numerous computational algorithms ([@b18-mmr-16-05-6608]). The present study obtained all the target genes of the 79 differentially expressed miRNAs according to three public databases. Subsequently, GO and KEGG analysis were used to identify the biological functions of these target genes.

The most enriched GO terms of the three ontologies are listed in [Tables IV](#tIV-mmr-16-05-6608){ref-type="table"}--[VI](#tVI-mmr-16-05-6608){ref-type="table"}. Transcription process, apoptosis process and cell proliferation process were among the most significantly enriched in terms of biological process; the cellular component GO analysis demonstrated that the target genes were associated with the nucleus, cytoplasm and cytosol; and protein binding, DNA binding, ATP binding and transcription factor binding were significantly enriched in terms of molecular function. Taken together, these results suggested that the target genes of differentially expressed miRNAs may be involved in cell proliferation, division, mitosis, apoptosis and differentiation. Finally, KEGG analysis indicated that 77 pathways were associated with the target genes of differentially expressed miRNAs; 15 significantly enriched pathways are presented in [Table VII](#tVII-mmr-16-05-6608){ref-type="table"}, including the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway, protein processing in endoplasmic reticulum, focal adhesion and mammalian target of rapamycin (mTOR) signaling, which are associated with cell growth, differentiation, apoptosis and migration.

Discussion
==========

In the present study, following incubation with GF109203X, some of the surviving keratinocytes reverted from a differentiated to a dedifferentiated state, as evidenced by the high colony-forming efficiency and expression of biological markers of keratinocyte stem cells, including intergrin β1, CK19 and CK14. However, in the CON group these alterations were not detected. These findings suggested that terminally differentiating epidermal keratinocytes may acquire some stem cell characteristics by modulation with GF109203X treatment. Therefore, dedifferentiation of human terminally differentiating keratinocytes may be induced by GF109203X *in vitro*. Mature cell dedifferentiation is a popular phenomenon, in which terminally differentiating epidermal cells can revert to their ancestor cells by dedifferentiation; i.e., epidermal cells can revert from the 'old' differentiated state to the not fully differentiated 'young' state, or even the 'naive' state with the characteristics of epidermal stem cells. Previous studies have confirmed that keratinocytes can be dedifferentiated into their progenitor cells, and have identified that dedifferentiated young epidermal cells may be used to treat severe wounds ([@b19-mmr-16-05-6608],[@b20-mmr-16-05-6608]). In addition, Sun *et al* ([@b21-mmr-16-05-6608]) demonstrated that dedifferentiation of human terminally differentiating keratinocytes into their precursor cells may be induced by basic fibroblast growth factor. Another study indicated that dedifferentiated epidermal cells are able to form clones and generate a complete epithelium following migration to cutaneous wounds ([@b22-mmr-16-05-6608]). Zhao *et al* ([@b23-mmr-16-05-6608]) demonstrated that LiCl and glycogen synthase kinase-3β inhibitor-induced cells are able to regenerate skin, in a manner equivalent to that of epidermal stem cells. These findings suggested that dedifferentiation is a promising method for the production of abundant epidermal stem cells, which may be used to bioengineer skin equivalents and as stem cell-based therapies in cutaneous repair and regeneration. It is well known that poor wound healing after trauma, surgery, acute illness or chronic disease conditions affects millions of people worldwide each year ([@b24-mmr-16-05-6608]), and the cost of non-healing wounds is a great burden to health care systems ([@b25-mmr-16-05-6608]). The efficacy of conventional approaches to treating cutaneous wounds is limited; dressings, periodic debridement, eliminating causative factors and innovations in surgical autologous grafting techniques are inherently limited to the size of available donor sites and are insufficient for global burn injuries ([@b26-mmr-16-05-6608]). Therefore, the present study offers a potential novel strategy for the treatment of cutaneous wounds. Furthermore, dedifferentiated cells are readily available in large quantities with the use of simple methods, and are considered moral and ethical alternatives for disease therapy, with no risk of genetic incompatibility or tissue rejection.

The present study used microarray hybridization to comparably observe the expression of miRNAs between EXP and CON groups. The results detected 45 upregulated miRNAs and 34 downregulated miRNAs when keratinocytes began exhibiting the characteristics of epidermal-like stem cells. In the present study, hsa-miR-1-3p was the most significantly upregulated miRNA and hsa-miR-31-5p was the most significantly downregulated miRNA. Hsa-miR-1-3p is also known as miR-1, which is significantly positively correlated with expression of the proliferation marker Ki67, and is involved in proliferation ([@b27-mmr-16-05-6608]). A previous study demonstrated that inhibition of PKC prevented the upregulation of miR-1 induced by constitutively active Gαi2, demonstrating a role for PKC in the regulation of muscle-specific miRNA ([@b28-mmr-16-05-6608]). In the present study, miR-1 was upregulated in keratinocytes treated with the PKC inhibitor GF109203X, which may also serve an important role in proliferation. Hsa-miR-31-5p is also known as miR-31, which has been implicated as a key regulator of keratinocyte differentiation and proliferation. Peng *et al* ([@b29-mmr-16-05-6608]) indicated that miR-31 is an endogenous negative regulator of factor inhibiting hypoxia-inducible factor-1 expression, which results in keratinocyte differentiation by enhancing Notch signaling; this finding is in accordance with the results of the present study. Furthermore, nuclear factor-κB-induced miR-31 promotes keratinocyte proliferation by suppressing protein phosphatase 6 in psoriasis ([@b30-mmr-16-05-6608]). Recently, in human metastatic cutaneous squamous cells, the increased expression of miR-31 was revealed to promote migration, invasion and colony forming ability ([@b31-mmr-16-05-6608]). Taken together, these findings suggested that miR-31 is a multifunctional miRNA that serves important roles in physiological and pathological conditions of epidermal keratinocytes; however, the molecular mechanisms of PKC and miR-31 remain poorly characterized and require further study. In addition, the present study demonstrated that miR-181c-5p and miR-374a were predominantly expressed in GF109203X-induced keratinocytes, which is in accordance with our previous observation that these miRNAs were upregulated in native keratinocyte stem cells ([@b6-mmr-16-05-6608]). Hsa-miR-181c-5p has functional relevance in the maintenance of stemness, which may regulate cell proliferation and cell cycle progression via the Notch signaling pathway and bone morphogenetic protein pathway in cancer stem cells ([@b32-mmr-16-05-6608]). In addition, miR-374a has been reported to promote the proliferation of osteosarcoma cells by targeting Axin2 ([@b33-mmr-16-05-6608]). Overall, these data indicated that these miRNAs may promote proliferation and maintain the undifferentiated state when keratinocytes were induced to re-express the biological characteristics of epidermal-like stem cells by GF109203X.

The enrichment analysis of the differentially expressed miRNAs demonstrated that hsa-miR-181c-5p, hsa-miR-378c and hsa-miR-20b-5p are involved in numerous KEGG pathways that regulate cell proliferation, differentiation and motility, which may serve important roles in dedifferentiation. Hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-590-5p, hsa-let-7f-5p and hsa-miR-378c are involved in the MAPK signaling pathway, which has been reported to be involved in cell proliferation, differentiation, inflammation and tumor growth ([@b34-mmr-16-05-6608],[@b35-mmr-16-05-6608]). PKCδ/p38δ MAPK signaling, which is a key controller of keratinocyte proliferation and differentiation, increases p21 (Cip1) expression to suppress keratinocyte proliferation ([@b36-mmr-16-05-6608]). A further study demonstrated that PKCδ/p38δ MAPK signaling suppresses methylosome protein 50 expression, leading to reduced H3/H4 arginine dimethylation at the p21 (Cip1) promoter; this was associated with enhanced p21 (Cip1) expression and reduced cell proliferation ([@b37-mmr-16-05-6608]). Previous research has indicated that the MAPK signaling pathway may increases p21 (Cip1) expression to suppress keratinocyte proliferation, which indicated that hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-590-5p, hsa-let-7f-5p and hsa-miR-378c may be associated with p21 (Cip1) expression and keratinocyte proliferation. In addition, the PI3K-Akt and mTOR signaling pathways may regulate the growth and differentiation of keratinocytes ([@b38-mmr-16-05-6608],[@b39-mmr-16-05-6608]), whereas the Hedgehog signaling pathway is a critical regulator of lineage-specific stem cells that maintains specialized sensory compartments in the epidermis ([@b40-mmr-16-05-6608]) which may serve a key role in re-expression of biological characteristics in induced keratinocytes.

The present study aimed to determine whether the differentially expressed miRNAs are associated with dedifferentiation of keratinocytes induced by GF109203X. It is well known that Oct-3/4, sex determine region Y-box 2 (Sox2), Nanog, c-Myc and Kruppel-like factor 4 (KLF4) are associated with dedifferentiation ([@b41-mmr-16-05-6608],[@b42-mmr-16-05-6608]). In cancer cells and mouse embryonic stem cells, zinc finger E-box binding homeobox 1 links epithelial-mesenchymal transition activation and maintenance of stemness by suppressing stemness-inhibiting miRNAs, including miR-200c, miR-203 and miR-183, which cooperate to suppress expression of stem cell factors, such as Sox2 and KlLF4 ([@b43-mmr-16-05-6608]). In addition, miR-134, miR-296 and miR-470, which are upregulated during retinoicacid-induced differentiation of mouse embryonic stem cells, target the amino acid coding sequence of Nanog, Oct4 and Sox2 genes, leading to transcriptional and morphological alterations characteristic of differentiating mouse embryonic stem cells, and resulting in a novel phenotype ([@b44-mmr-16-05-6608]). Lauschke *et al* ([@b45-mmr-16-05-6608]) identified that miRNAs are important drivers of hepatic dedifferentiation. Taken together, dedifferentiation is a process associated with modulation of numerous genes, in which miRNAs may have an important role; this may explain why were so many differentially expressed miRNAs were detected during GF109203X-induced keratinocyte dedifferentiation.

In conclusion, when treated with the PKC inhibitor GF109203X, keratinocytes exhibited a series of alterations, including altered morphology, expression of epidermal cell-specific markers and differentially expressed miRNAs. Bioinformatics analysis of the differentially expressed miRNAs indicated that inhibition of PKC signaling was associated with cell proliferation, differentiation and dedifferentiation. Considering that pre-clinical and clinical studies have demonstrated that modulation of miRNA expression by administration of specific miRNA mimics or inhibitors may be beneficial for treating diseases ([@b46-mmr-16-05-6608]), the present study may offer novel miRNAs for regulation of the PKC pathway. However, the exact mechanisms underlying the differentially expressed miRNAs remain unclear and require further study.
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![(A) Ribosomal RNA on a denaturing agarose gel. Lane 1, EXP group; lane 2, CON group. (B) Scatter plot for fluorescence signal intensity of the miRNAs in the two groups. Axes represent the fluorescence signal intensity of the miRNAs in chips, and each point represents the fluorescence signal intensity of one probe set (miRNA). (C) Hierarchical clustering in the EXP and CON groups. Red represents up-regulation, green represents down-regulation. EXP, experimental; CON, control; miRNA, microRNA.](mmr-16-05-6608-g00){#f1-mmr-16-05-6608}

![(A-C) Amplification and (D-F) dissociation curve charts for (A and D) hsa-miR-1-3p, (B and E) hsa-miR-31-5p and (C and F) U6. In the amplification curve charts, the x-axis represents cycle number and the y-axis represents the real-time fluorescence signal intensity of the corresponding cycle number. In the dissociation curve charts, the x-axis represents the temperature of the RT-qPCR products and the y-axis represents the real-time fluorescence-signal-intensity change rate with increasing temperature. Differently colored curves correspond to different RT-qPCRs. miR, microRNA; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.](mmr-16-05-6608-g01){#f2-mmr-16-05-6608}

###### 

Primer sequences used for quantitative polymerase chain reaction.

  miRNA           Sequences                         Annealing temperature (°C)   Product length (bp)
  --------------- --------------------------------- ---------------------------- ---------------------
  U6              F:5′GCTTCGGCAGCACATATACTAAAAT3′                                
                  R:5′CGCTTCACGAATTTGCGTGTCAT3′     60                           89
  hsa-miR-1-3p    GSP:5′GGGGCTGGAATGTAAAGAAGT3′                                  
                  R:5′GTGCGTGTCGTGGAGTCG3′          60                           65
  hsa-miR-31-5p   F:5′GGAGGCAAGATGCTGGC3′                                        
                  R:5′CAGTGCGTGTCGTGGAGT3′          60                           64

miRNA/miR, microRNA; F, forward; R, reverse.

###### 

RNA quantification and quality assurance, as determined by NanoDropND-1000.

  Group   OD260/280 ratio   OD260/230 ratio   Concentration (ng/µl)   Quantity (ng)   Result
  ------- ----------------- ----------------- ----------------------- --------------- --------
  EXP     1.85              2.12              101.82                  1018.2          Pass
  CON     1.86              2.06              337.7                   3377            Pass

EXP, experimental; CON, control; OD, optical density.

###### 

Differential expression of miRNAs.

  miRNA probe ID   miRNA                EXP/CON
  ---------------- -------------------- -----------
  Upregulated                           
    10916          hsa-miR-1-3p         5.026537
    42660          hsa-miR-144-5p       3.747800
    145844         hsa-miR-374a-5p      3.715758
    148228         hsa-miR-3656         3.560661
    168635         hsa-miR-378e         3.138800
    147755         hsa-miR-378c         2.817634
    42654          hsa-miR-483-5p       2.683051
    46944          hsa-miR-1297         2.674556
    147851         hsa-miR-3201         2.632528
    147604         hsa-miR-4285         2.624769
    29577          hsa-miR-374a-3p      2.570440
    168935         hsa-miR-4687-3p      2.562501
    146072         hsa-miR-1469         2.484515
    168944         hsa-miR-4707-5p      2.460301
    17752          hsa-let-7f-5p        2.456365
    11053          hsa-miR-32-5p        2.405171
    33596          hsa-miR-126-5p       2.382427
    147926         hsa-miR-4329         2.377924
    27536          hsa-miR-190a-5p      2.370629
    42782          hcmv-miR-UL148D      2.338837
    42640          hsa-miR-20b-5p       2.337647
    11004          hsa-miR-203a-3p      2.295231
    169221         hsa-miR-4748         2.294769
    169230         hsa-miR-4747-3p      2.281731
    17503          hsa-miR-590-5p       2.268278
    147840         hsv2-miR-H9-3p       2.262449
    4040           hsa-miR-9-5p         2.239972
    169395         hsa-miR-4484         2.239785
    148620         hsa-miR-454-3p       2.196783
    42800          hsa-miR-582-5p       2.188416
    17315          kshv-miR-K12-3-3p    2.175560
    169399         hsa-miR-4750-5p      2.144243
    10923          hsa-miR-107          2.143846
    169183         hsa-miR-4644         2.128833
    169170         hsa-miR-4472         2.104725
    146089         hsv1-miR-H8-5p       2.094303
    168696         hsa-miR-4739         2.094056
    168893         hsa-miR-4505         2.093298
    169272         hsa-miR-4419b        2.080859
    42496          hsa-miR-181c-5p      2.041768
    169110         hsa-miR-4497         2.040852
    168670         hsa-miR-4694-5p      2.031255
    146086         hsa-miR-30a-5p       2.030778
    148509         hsa-miR-328-5p       2.028205
    169375         Has-miR-660-3p       2.005712
  Downregulated                         
    11052          hsa-miR-31-5p        13.901180
    42668          hsa-let-7c-3p        7.137004
    42959          hsa-miR-514a-3p      6.094606
    169159         hsa-miR-4521         4.968959
    147809         hsa-miR-514b-3p      4.793510
    17848          hsa-miRPlus-A1087    4.497239
    42686          hsa-miR-136-3p       4.108723
    148402         hsa-miR-3920         3.275565
    145689         hsa-miR-543          2.614642
    42516          kshv-miR-K12-12-5p   2.564381
    147842         hsv2-miR-H11-5p      2.556539
    11023          hsa-miR-222-3p       2.505895
    145838         hsa-miR-125b-1-3p    2.407407
    11140          hsa-miR-508-3p       2.396755
    11139          hsa-miR-507          2.307986
    29379          hsa-miR-452-5p       2.302862
    168958         hsa-miR-2681-5p      2.283967
    11037          hsa-miR-299-3p       2.269868
    145914         hsa-miR-135b-5p      2.266023
    168606         hsa-miR-4633-5p      2.253791
    169239         hsa-miR-4732-5p      2.236971
    46789          hsa-miR-513b-5p      2.213730
    169379         hsa-miR-4694-3p      2.194923
    147501         hsa-miR-98-3p        2.165957
    46917          hsa-miR-205-5p       2.142624
    145751         hsa-miR-23b-5p       2.138643
    148278         hsa-miR-138-2-3p     2.126352
    168963         hsa-miR-664b-5p      2.123429
    146111         hsa-miR-767-5p       2.105775
    168953         hsa-miR-4704-5p      2.097161
    146165         hsa-miR-1973         2.089585
    29190          hsa-miR-708-5p       2.072155
    17818          hsa-miR-27a-5p       2.064144
    31076          hsa-miR-559          2.018320

miR/miRNA, microRNA; EXP, experimental; CON, control.

###### 

Enriched terms in GO biological process.

  Term ID      Term name                                                              Hit number
  ------------ ---------------------------------------------------------------------- ------------
  GO:0006351   Transcription, DNA-dependent                                           514
  GO:0006355   Regulation of transcription, DNA-dependent                             328
  GO:0045944   Positive regulation of transcription from RNA polymerase II promoter   259
  GO:0007165   Signal transduction                                                    243
  GO:0006915   Apoptotic process                                                      216
  GO:0045893   Positive regulation of transcription, DNA-dependent                    200
  GO:0000122   Negative regulation of transcription from RNA polymerase II promoter   198
  GO:0010467   Gene expression                                                        181
  GO:0045892   Negative regulation of transcription, DNA-dependent                    161
  GO:0043066   Negative regulation of apoptotic process                               143
  GO:0008285   Negative regulation of cell proliferation                              123
  GO:0006366   Transcription from RNA polymerase II promoter                          112
  GO:0008284   Positive regulation of cell proliferation                              105
  GO:0008283   Cell proliferation                                                     99
  GO:0051301   Cell division                                                          94
  GO:0007049   Cell cycle                                                             85
  GO:0006357   Regulation of transcription from RNA polymerase II promoter            79
  GO:0006367   Transcription initiation from RNA polymerase II promoter               73
  GO:0016055   Wnt receptor signaling pathway                                         65
  GO:0001525   Angiogenesis                                                           65
  GO:0043065   Positive regulation of apoptotic process                               64
  GO:0007173   Epidermal growth factor receptor signaling pathway                     62
  GO:0006917   Induction of apoptosis                                                 60
  GO:0007050   Cell cycle arrest                                                      58
  GO:0007067   Mitosis                                                                58
  GO:0000082   G~1~/S transition of mitotic cell cycle                                47
  GO:0007243   Intracellular protein kinase cascade                                   43
  GO:0007219   Notch signaling pathway                                                43
  GO:0006260   DNA replication                                                        42
  GO:0030335   Positive regulation of cell migration                                  41
  GO:0016477   Cell migration                                                         40
  GO:0019827   Stem cell maintenance                                                  40

GO, Gene Ontology.

###### 

Enriched terms in GO molecular functions.

  Term ID      Term name                                                     Hit number
  ------------ ------------------------------------------------------------- ------------
  GO:0005515   Protein binding                                               1,554
  GO:0003677   DNA binding                                                   428
  GO:0005524   ATP binding                                                   413
  GO:0003700   Sequence-specific DNA binding transcription factor activity   295
  GO:0043565   Sequence-specific DNA binding                                 166
  GO:0003723   RNA binding                                                   142
  GO:0003682   Chromatin binding                                             126
  GO:0008134   Transcription factor binding                                  111
  GO:0042802   Identical protein binding                                     109
  GO:0019901   Protein kinase binding                                        104
  GO:0005525   GTP binding                                                   98
  GO:0003713   Transcription coactivator activity                            91
  GO:0003714   Transcription corepressor activity                            70
  GO:0004672   Protein kinase activity                                       70
  GO:0019899   Enzyme binding                                                67
  GO:0003924   GTPase activity                                               67
  GO:0044212   Transcription regulatory region DNA binding                   63
  GO:0019904   Protein domain specific binding                               58
  GO:0008022   Protein C-terminus binding                                    51
  GO:0003705   RNA polymerase II distal enhancer sequence-specific           39
               DNA binding transcription factor activity                     
  GO:0005096   GTPase activator activity                                     37
  GO:0004725   Protein tyrosine phosphatase activity                         36
  GO:0001077   RNA polymerase II core promoter proximal region               32
               Sequence-specific DNA binding transcription factor            
               Activity involved in positive regulation of transcription     

GO, Gene Ontology.

###### 

Enriched terms in GO cell component.

  Term Id      Term name                                  Hit number
  ------------ ------------------------------------------ ------------
  GO:0005634   Nucleus                                    1,321
  GO:0005737   Cytoplasm                                  1,104
  GO:0005829   Cytosol                                    668
  GO:0005730   Nucleolus                                  459
  GO:0005654   Nucleoplasm                                303
  GO:0005794   Golgi apparatus                            213
  GO:0016020   Membrane                                   198
  GO:0005783   Endoplasmic reticulum                      168
  GO:0005789   Endoplasmic reticulum membrane             167
  GO:0048471   Perinuclear region of cytoplasm            150
  GO:0000139   Golgi membrane                             139
  GO:0043231   Intracellular membrane-bounded organelle   110
  GO:0005667   Transcription factor complex               83
  GO:0005925   Focal adhesion                             50
  GO:0031965   Nuclear membrane                           50
  GO:0005765   Lysosomal membrane                         43
  GO:0005938   Cell cortex                                40
  GO:0005741   Mitochondrial outer membrane               39
  GO:0005911   Cell-cell junction                         36
  GO:0005819   Spindle                                    34
  GO:0000790   Nuclear chromatin                          32
  GO:0000151   Ubiquitin ligase complex                   25
  GO:0017053   Transcriptional repressor complex          22

GO, Gene Ontology.

###### 

Pathways associated with the differentially expressed miRNAs.

  Pathway                                       Function                                                                                                                                                                                                               Related differentially expressed miRNAs
  --------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------
  PI3K-Akt signaling pathway                    Activated by many types of cellular stimuli or toxic insults; regulates fundamental cellular functions, including transcription, translation, proliferation, growth and survival                                       hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-1297, hsa-miR-378e, hsa-miR-378c
  MAPK signaling pathway                        Highly conserved module, involved in various cellular functions, including cell proliferation, differentiation and migration                                                                                           hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-590-5p, hsa-let-7f-5p, hsa-miR-378c, hsa-miR-299-3p
  Protein processing in endoplasmic reticulum   Promotes cell apoptosis                                                                                                                                                                                                hsa-miR-181c-5p, hsa-miR-1297, hsa-miR-374a-5p, hsa-miR-299-3p, hsa-miR-20b-5p
  Focal adhesion                                Serves essential roles in important biological processes, including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival                                           hsa-miR-1-3p, hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-378e, hsa-miR-4644, hsa-miR-378c
  Hippo signaling pathway                       Promotes Mats localization in the cytoplasm, leading to cell apoptosis and restricting organ size overgrowth                                                                                                           hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-4644
  Wnt signaling pathway                         Required for basic developmental processes, including cell-fate specification, progenitor-cell proliferation and control of asymmetric cell division                                                                   hsa-miR-20b-5p, hsa-miR-1297, hsa-miR-374a-5p, hsa-miR-222-3p, hsa-miR-135b-5p
  Cell cycle                                    Regulation of cell mitosis                                                                                                                                                                                             hsa-miR-1-3p, hsa-miR-20b-5p, hsa-miR-1297
  TGF-β signaling pathway                       TGF-β family members are involved in a wide spectrum of cellular functions, including proliferation, apoptosis, differentiation and migration                                                                          hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-374a-5p, hsa-miR-590-5p, hsa-miR-454-3p, hsa-miR-135b-5p
  Adherens junction                             Important for maintaining tissue architecture and cell polarity, and can limit cell movement and proliferation                                                                                                         hsa-miR-181c-5p, hsa-miR-1-3p, hsa-miR-20b-5p, hsa-miR-378e, hsa-miR-4644, hsa-miR-378c
  p53 signaling pathway                         p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes, thus resulting in three major outputs: Cell cycle arrest, cellular senescence and apoptosis   hsa-miR-1297
  Apoptosis                                     Apoptosis is a genetically controlled mechanism of cell death involved in the regulation of tissue homeostasis                                                                                                         hsa-miR-20b-5p
  Hedgehog signaling pathway                    Involved in control of stem cell proliferation in adult tissues                                                                                                                                                        hsa-miR-4644
  mTOR signaling pathway                        Regulates cell growth and cell differentiation                                                                                                                                                                         hsa-miR-181c-5p, hsa-miR-20b-5p, hsa-miR-454-3p
  ErbB signaling pathway                        Regulates diverse biological responses, including proliferation, differentiation, cell motility and survival                                                                                                           hsa-miR-181c-5p, hsa-miR-378e, hsa-miR-4644, hsa-miR-378c
  VEGF signaling pathway                        Mediates the proliferation and migration of endothelial cells, and promotes their survival and vascular permeability                                                                                                   hsa-miR-1-3p, hsa-miR-4644

miRNA/miR, microRNA; PI3K, phosphoinositide 3-kinase; MAPK, mitogen-activated protein kinase; TGF, transforming growth factor; mTOR, mammalian target of rapamycin; VEGF, vascular endothelial growth factor.
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